サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/07/12 | 1,297 | 1,308 | 1,281 | 1,304 | +18 | +1.4% | 387,700 |
| 2021/07/09 | 1,260 | 1,291 | 1,260 | 1,286 | -4 | -0.3% | 494,500 |
| 2021/07/08 | 1,327 | 1,327 | 1,282 | 1,290 | -47 | -3.5% | 631,500 |
| 2021/07/07 | 1,363 | 1,363 | 1,331 | 1,337 | -35 | -2.6% | 493,500 |
| 2021/07/06 | 1,385 | 1,435 | 1,363 | 1,372 | -21 | -1.5% | 491,700 |
| 2021/07/05 | 1,440 | 1,440 | 1,390 | 1,393 | -37 | -2.6% | 681,400 |
| 2021/07/02 | 1,444 | 1,457 | 1,419 | 1,430 | -55 | -3.7% | 460,800 |
| 2021/07/01 | 1,414 | 1,489 | 1,409 | 1,485 | +77 | +5.5% | 663,800 |
| 2021/06/30 | 1,432 | 1,437 | 1,403 | 1,408 | -22 | -1.5% | 382,400 |
| 2021/06/29 | 1,433 | 1,440 | 1,425 | 1,430 | -11 | -0.8% | 216,000 |
| 2021/06/28 | 1,443 | 1,454 | 1,429 | 1,441 | -5 | -0.3% | 207,200 |
| 2021/06/25 | 1,452 | 1,452 | 1,419 | 1,446 | -6 | -0.4% | 213,600 |
| 2021/06/24 | 1,455 | 1,478 | 1,446 | 1,452 | -17 | -1.2% | 205,000 |
| 2021/06/23 | 1,451 | 1,470 | 1,439 | 1,469 | +14 | +1% | 259,800 |
| 2021/06/22 | 1,425 | 1,457 | 1,411 | 1,455 | +51 | +3.6% | 392,600 |
| 2021/06/21 | 1,405 | 1,418 | 1,399 | 1,404 | -31 | -2.2% | 488,400 |
| 2021/06/18 | 1,444 | 1,450 | 1,422 | 1,435 | -9 | -0.6% | 411,400 |
| 2021/06/17 | 1,487 | 1,491 | 1,437 | 1,444 | -37 | -2.5% | 433,600 |
| 2021/06/16 | 1,453 | 1,488 | 1,432 | 1,481 | +9 | +0.6% | 490,700 |
| 2021/06/15 | 1,492 | 1,499 | 1,457 | 1,472 | -31 | -2.1% | 647,900 |
| 2021/06/14 | 1,531 | 1,535 | 1,483 | 1,503 | -39 | -2.5% | 477,500 |
| 2021/06/11 | 1,558 | 1,558 | 1,522 | 1,542 | -5 | -0.3% | 383,200 |
| 2021/06/10 | 1,581 | 1,585 | 1,533 | 1,547 | -43 | -2.7% | 561,100 |
| 2021/06/09 | 1,574 | 1,675 | 1,574 | 1,590 | +18 | +1.1% | 1,310,400 |
| 2021/06/08 | 1,537 | 1,610 | 1,515 | 1,572 | +50 | +3.3% | 836,500 |
| 2021/06/07 | 1,555 | 1,558 | 1,474 | 1,522 | +2 | +0.1% | 643,600 |
| 2021/06/04 | 1,415 | 1,545 | 1,402 | 1,520 | +96 | +6.7% | 1,247,700 |
| 2021/06/03 | 1,436 | 1,449 | 1,417 | 1,424 | -14 | -1% | 219,400 |
| 2021/06/02 | 1,421 | 1,464 | 1,420 | 1,438 | +9 | +0.6% | 286,600 |
| 2021/06/01 | 1,445 | 1,445 | 1,421 | 1,429 | -16 | -1.1% | 278,500 |
| 2021/05/31 | 1,455 | 1,475 | 1,435 | 1,445 | -12 | -0.8% | 273,900 |
| 2021/05/28 | 1,447 | 1,478 | 1,446 | 1,457 | +17 | +1.2% | 194,600 |
| 2021/05/27 | 1,450 | 1,468 | 1,439 | 1,440 | -25 | -1.7% | 277,400 |
| 2021/05/26 | 1,456 | 1,472 | 1,438 | 1,465 | -4 | -0.3% | 251,200 |
| 2021/05/25 | 1,478 | 1,490 | 1,465 | 1,469 | -5 | -0.3% | 259,600 |
| 2021/05/24 | 1,549 | 1,549 | 1,465 | 1,474 | -92 | -5.9% | 512,200 |
| 2021/05/21 | 1,512 | 1,574 | 1,504 | 1,566 | +59 | +3.9% | 282,900 |
| 2021/05/20 | 1,492 | 1,528 | 1,483 | 1,507 | -3 | -0.2% | 222,700 |
| 2021/05/19 | 1,475 | 1,517 | 1,469 | 1,510 | +15 | +1% | 230,100 |
| 2021/05/18 | 1,440 | 1,497 | 1,428 | 1,495 | +50 | +3.5% | 253,200 |
| 2021/05/17 | 1,486 | 1,494 | 1,436 | 1,445 | -34 | -2.3% | 266,400 |
| 2021/05/14 | 1,465 | 1,498 | 1,463 | 1,479 | +16 | +1.1% | 216,000 |
| 2021/05/13 | 1,455 | 1,505 | 1,428 | 1,463 | -17 | -1.1% | 409,700 |
| 2021/05/12 | 1,503 | 1,523 | 1,459 | 1,480 | -31 | -2.1% | 404,800 |
| 2021/05/11 | 1,541 | 1,541 | 1,506 | 1,511 | -40 | -2.6% | 216,900 |
| 2021/05/10 | 1,538 | 1,561 | 1,521 | 1,551 | +20 | +1.3% | 200,200 |
| 2021/05/07 | 1,518 | 1,533 | 1,502 | 1,531 | +15 | +1% | 183,400 |
| 2021/05/06 | 1,517 | 1,549 | 1,511 | 1,516 | +15 | +1% | 213,700 |
| 2021/04/30 | 1,515 | 1,520 | 1,496 | 1,501 | -27 | -1.8% | 309,200 |
| 2021/04/28 | 1,558 | 1,562 | 1,525 | 1,528 | -29 | -1.9% | 278,200 |
951～
1000
件表示中 / 2479件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 322,000円 | - | - | 0.00% | - | 149.14倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ツムラ | 335,500円 | +3.8% | -19.9% | 4.05% | 10.97倍 | 0.84倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 355,000円 | +8.0% | -15.3% | 3.49% | 9.97倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 169,800円 | +5.0% | +1.5% | 0.00% | 14.52倍 | 3.86倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ジーエヌアイ | 406,000円 | +21.7% | +999.9% | 0.00% | 17.01倍 | 5.63倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
